Too early and widespread expression of PAX3-FOXO1 expression can result in developmental defects and no apparent tumor development [120-123], whereas later expression of PAX3-FOXO1, via a Myf6-driven Cre recombinase, does cause disease, though at a low frequency [47]. The gene discussed is PAX3; the disease is neoplasm.